Literature DB >> 17638704

Sexual dimorphism in cortisol secretion starts after age 10 in healthy children: urinary cortisol metabolite excretion rates during growth.

Stefan A Wudy1, Michaela F Hartmann, Thomas Remer.   

Abstract

Detailed data on the physiological pattern of adrenocortical activity during normal growth are lacking. An established method to determine adrenocortical glucocorticoid secretion is the measurement of 24-h excretion rates of major urinary cortisol metabolites (C21). To test the hypothesis that the frequently reported higher cortisol secretion in men than in women develops during puberty, we examined C21 together with excretions of combined urinary free and conjugated cortisol (F(comb)) in 400 healthy boys and girls aged 3-18 yr using GC-MS. Daily excretion rates of C21, F(comb), and body surface area (BSA)-corrected F(comb) significantly increased with age in both sexes. In contrast, C21/BSA (microgxm(-2).day(-1)) declined from the age of 3-4 yr to 7-8 yr in boys and girls (P < 0.01; e.g., in boys: from 3,991 +/- 1,167 to 3,193 +/- 804), then increased in both sexes, and finally became discordant after the age of 11-12 yr with a further rise in males only (17- to 18-yr-olds: boys, 5,275 +/- 1,414; girls 3,939 +/- 1,586, P < 0.01). This pattern was associated with the occurrence of a lower index for 5alpha-reductase activity (allotetrahydrocortisol/tetrahydrocortisol) in females compared with males. Our results demonstrate dynamic changes in adrenocortical activity in healthy children resulting in an emerging sexual dimorphism in cortisol secretion after age 11. The latter can be explained, at least partly, by diverging 5alpha-reductase activities in boys and girls. F(comb), a frequently analyzed GC-MS parameter, proved not to reflect dynamic changes in cortisol secretion. In conclusion, the varying metabolic need for cortisol during normal growth may have implications for future improvements in glucocorticoid replacement therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638704     DOI: 10.1152/ajpendo.00495.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  24 in total

1.  Is iodine intake in Germany almost adequate or even optimal and do nonalcoholic beverages relevantly contribute to iodine status?

Authors:  Thomas Remer
Journal:  Eur J Nutr       Date:  2009-04       Impact factor: 5.614

2.  Reply to: A systematic review and meta-analysis of 24-h urinary output of children and adolescents: impact on the assessment of iodine status using urinary biomarkers-don't forget creatinine.

Authors:  Kelsey Beckford; Carley A Grimes; Claire Margerison; Lynn J Riddell; Sheila A Skeaff; Madeline L West; Caryl A Nowson
Journal:  Eur J Nutr       Date:  2021-01-13       Impact factor: 5.614

3.  Adrenarche and middle childhood.

Authors:  Benjamin C Campbell
Journal:  Hum Nat       Date:  2011-09

4.  Iodine status in preschool children and evaluation of major dietary iodine sources: a German experience.

Authors:  Simone A Johner; Michael Thamm; Ute Nöthlings; Thomas Remer
Journal:  Eur J Nutr       Date:  2012-12-02       Impact factor: 5.614

5.  Emergence of Sex Differences in Insomnia Symptoms in Adolescents: A Large-Scale School-Based Study.

Authors:  Jihui Zhang; Ngan Yin Chan; Siu Ping Lam; Shirley Xin Li; Yaping Liu; Joey W Y Chan; Alice Pik Shan Kong; Ronald C W Ma; Kate C C Chan; Albert Martin Li; Yun-Kwok Wing
Journal:  Sleep       Date:  2016-08-01       Impact factor: 5.849

6.  Acute effects of physical exercise and phosphodiesterase's type 5 inhibition on serum 11β-hydroxysteroid dehydrogenases related glucocorticoids metabolites: a pilot study.

Authors:  Luigi Di Luigi; Francesco Botrè; Stefania Sabatini; Massimiliano Sansone; Monica Mazzarino; Laura Guidetti; Carlo Baldari; Andrea Lenzi; Daniela Caporossi; Francesco Romanelli; Paolo Sgrò
Journal:  Endocrine       Date:  2014-02-15       Impact factor: 3.633

7.  Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency.

Authors:  Eli Hershkovitz; Ruthi Parvari; Stefan A Wudy; Michaela F Hartmann; Larissa G Gomes; Neta Loewental; Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2008-06-17       Impact factor: 5.958

8.  Cortisol and 11 beta-hydroxysteroid dehydrogenase type 2 as potential determinants of renal citrate excretion in healthy children.

Authors:  Yifan Hua; Jonas Esche; Michaela F Hartmann; Christiane Maser-Gluth; Stefan A Wudy; Thomas Remer
Journal:  Endocrine       Date:  2019-12-07       Impact factor: 3.633

Review 9.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

Review 10.  Sexual Dimorphism of Corticosteroid Signaling during Kidney Development.

Authors:  Margaux Laulhé; Laurence Dumeige; Thi An Vu; Imene Hani; Eric Pussard; Marc Lombès; Say Viengchareun; Laetitia Martinerie
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.